TriaGen Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Sell |
23,771
-1,160
| -5% | -$125K | 0.77% | 29 |
|
|
2025
Q1 | $2.52M | Sell |
24,931
-441
| -2% | -$44.5K | 0.89% | 24 |
|
|
2024
Q4 | $2.27M | Sell |
25,372
-22
| -0.1% | -$1.97K | 0.76% | 31 |
|
|
2024
Q3 | $2.13M | Hold |
25,394
| – | – | 0.71% | 34 |
|
|
2024
Q2 | $1.96M | Sell |
25,394
-148
| -0.6% | -$11.4K | 0.76% | 41 |
|
|
2024
Q1 | $1.75M | Sell |
25,542
-7
| -0% | -$479 | 0.73% | 44 |
|
|
2023
Q4 | $1.48M | Sell |
25,549
-229
| -0.9% | -$13.2K | 0.7% | 46 |
|
|
2023
Q3 | $1.36M | Sell |
25,778
-163
| -0.6% | -$8.61K | 0.69% | 47 |
|
|
2023
Q2 | $1.4M | Hold |
25,941
| – | – | 0.64% | 55 |
|
|
2023
Q1 | $1.3M | Sell |
25,941
-281
| -1% | -$14.1K | 0.65% | 50 |
|
|
2022
Q4 | $1.21M | Buy |
+26,222
| New | +$1.21M | 0.67% | 43 |
|
|
2021
Q4 | – | Sell |
-11,796
| Closed | -$512K | – | 184 |
|
|
2021
Q3 | $512K | Buy |
+11,796
| New | +$512K | 0.28% | 98 |
|